Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TN/Chattanooga
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Chattanooga, TN

Studies commonly pay $75 to $4,500 per completed study

137 clinical trials are currently recruiting participants within 30 miles of Chattanooga. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

137studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Chattanooga right now

Top 25 of 137 recruiting studies, sorted by proximity — each links to its official registry page

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Brain Tumor, Recurrent, Brain Tumor N/A Observational 600 participants sought
CHI Memorial Hospital, CommonSpirit — Chattanooga, Tennessee (3.8 mi) · Sponsor: GT Medical Technologies, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04427384)

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Phase 3 Interventional 5,951 participants sought
T C Thompson Children's Hospital — Chattanooga, Tennessee (3.8 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT03959085)

Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis

Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital Phase 3 Interventional 400 participants sought
Chattanooga Medical Research, Chattanooga — Chattanooga, Tennessee (3.8 mi) · Sponsor: pH-D Feminine Health LLC
See eligibility & contact on ClinicalTrials.gov (NCT07109869)

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer Phase 3 Interventional 186 participants sought
Erlanger Health, Inc. — Chattanooga, Tennessee (3.8 mi) · Sponsor: Genelux Corporation
See eligibility & contact on ClinicalTrials.gov (NCT05281471)

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular Risk, Acute Myocardial Infarction (AMI) Phase 3 Interventional 10,000 participants sought
Chattanooga Heart Institute — Chattanooga, Tennessee (3.8 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT06118281)

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 1,200 participants sought
Tennessee Oncology-Chattanooga ( Site 0045) — Chattanooga, Tennessee (3.8 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06136559)

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

Multiple Myeloma Phase 1, Phase 2 Interventional 123 participants sought
GSK Investigational Site — Chattanooga, Tennessee (3.8 mi) · Sponsor: GlaxoSmithKline
See eligibility & contact on ClinicalTrials.gov (NCT05714839)

A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)

Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 600 participants sought
Site 60 — Chattanooga, Tennessee (3.8 mi) · Sponsor: Merus B.V.
See eligibility & contact on ClinicalTrials.gov (NCT06496178)

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

Focal Segmental Glomerulosclerosis Phase 3 Interventional 286 participants sought
Southeast Renal Research Institute — Chattanooga, Tennessee (3.8 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07220083)

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Recurrent or Metastatic Solid Tumors Phase 1, Phase 2 Interventional 680 participants sought
Erlanger Health, Inc — Chattanooga, Tennessee (3.8 mi) · Sponsor: Daiichi Sankyo
See eligibility & contact on ClinicalTrials.gov (NCT06330064)

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

Generalized Myasthenia Gravis Phase 3 Interventional 264 participants sought
Erlanger Health, Inc. - 1123255 — Chattanooga, Tennessee (3.8 mi) · Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
See eligibility & contact on ClinicalTrials.gov (NCT06463587)

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis Phase 2 Interventional 168 participants sought
Nephrology & Hypertension Specialists — Dalton, Georgia (25.8 mi) · Sponsor: R1 Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06712654)

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma Phase 2 Interventional 130 participants sought
Tennessee Oncology — Chattanooga, Tennessee (3.8 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06806033)

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

Graves' Disease Phase 2 Interventional 240 participants sought
Site Number - 1042 — Chattanooga, Tennessee (3.8 mi) · Sponsor: Immunovant Sciences GmbH
See eligibility & contact on ClinicalTrials.gov (NCT06727604)

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

Atrial Fibrillation (AF) Phase 3 Interventional 2,500 participants sought
Anthos Investigational site 9954 — Chattanooga, Tennessee (3.8 mi) · Sponsor: Anthos Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05712200)

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

Eosinophilic Asthma Phase 2 Interventional 264 participants sought
Kymera Investigative Site — Chattanooga, Tennessee (3.8 mi) · Sponsor: Kymera Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07323654)

A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis

Myasthenia Gravis, Generalized Phase 2 Interventional 30 participants sought
Ut Erlanger Neurology — Chattanooga, Tennessee (3.8 mi) · Sponsor: Vertex Pharmaceuticals Incorporated
See eligibility & contact on ClinicalTrials.gov (NCT07501702)

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

End Stage Kidney Disease Phase 2, Phase 3 Interventional 3,110 participants sought
Southeast Renal Research Institute — Chattanooga, Tennessee (3.8 mi) · Sponsor: CSL Behring
See eligibility & contact on ClinicalTrials.gov (NCT05485961)

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Colorectal Neoplasms Phase 3 Interventional 700 participants sought
Tennessee Oncology Chattanooga — Chattanooga, Tennessee (3.8 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06750094)

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Metabolic Dysfunction-Associated Steatotic Liver Disease Phase 3 Interventional 4,500 participants sought
Galen Medical Group - Galen Hepatology — Chattanooga, Tennessee (3.8 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07165028)

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial Meningioma, Recurrent Meningioma Phase 2 Interventional 124 participants sought
Memorial Hospital — Chattanooga, Tennessee (3.8 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02523014)

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Non-small Cell Lung Cancer Phase 3 Interventional 868 participants sought
Greco-Hainsworth Centers for Research ( Site 4034) — Chattanooga, Tennessee (3.8 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06077760)

PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease

Proteinuric Kidney Diseases Phase 2 Interventional 132 participants sought
Southeast Renal Research Institute — Chattanooga, Tennessee (3.8 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07355296)
Actively enrolling

Studies you may be able to join near Chattanooga

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Chattanooga

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

M3 Wake Research Chattanooga

★ 4.5
6035 Shallowford Rd, Chattanooga, TN 37421
(423) 698-4584
"Great friendly staff, get paid for participating in qualified medical research."
— Tyler Yeager, 5★

Nova Research Trials

725 Glenwood Dr Ste 686, Chattanooga, TN 37404
(423) 703-0888

Lynn Institute of Chattanooga

Located in the Missionary Ridge Medical Tower, 725 Glenwood Dr #888, Chattanooga, TN 37404
(423) 713-5966

Chattanooga Research & Medicine

2205 McCallie Ave Ste 301, Chattanooga, TN 37404
(423) 643-2253

Chattanooga Medical Research

★ 5.0
929 Spring Creek Rd, Chattanooga, TN 37412
(423) 648-7794

Wilkins Research Services

★ 4.0
1730 Gunbarrel Rd, Chattanooga, TN 37421
(423) 894-9478
"I had my very first focus group today and I was nervous since I have never done anything like his before. They were extremely sweet, offered us drink…"
— Leila Parker, 5★

Erlanger Endocrinology

★ 2.3
979 E 3rd St Ste A-550, Chattanooga, TN 37403
(423) 778-8224
"Have an appointment today after waiting for 3 months but I haven't been able to get ahold of anyone at the office. They absolutely suck . Please if …"
— sticky mess, 1★

Southeast Clinical Research Center

1102 W Waugh St, Dalton, GA 30720
(706) 913-1779

Scenic City Neurotherapy and Ketamine Center

★ 4.9 (82 reviews)
7405 Shallowford Rd STE 240, Chattanooga, TN 37421
(423) 228-0579
"Exceptional staff across the board. Charles and Brian are incredible providers, Connie, the receptionist is a joy to talk to and be welcomed by every…"
— James Dietzen, 5★

Clinical trials in Chattanooga: what's recruiting

The Chattanooga area currently has 137 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Chattanooga, the most active research areas are:

  • Cancer & Oncology10 studies
  • Liver & Kidney4 studies
  • Heart & Vascular1 studies
  • Lungs & Breathing1 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Chattanooga, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Chattanooga

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Chattanooga participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Chattanooga pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Chattanooga?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Chattanooga safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Chattanooga?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Paid clinical trials near Chattanooga

Other metros within reach

Murfreesboro, TN84 Huntsville, AL92 Atlanta, GA1,715 Knoxville, TN236 Gainesville, GA147 Nashville, TN1,349 Birmingham, AL971 Athens, GA71

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Chattanooga Bladder Issues Due To Spinal Cord Injury in Chattanooga All conditions

More of TN

Nashville1,349 Memphis592 Knoxville236 Murfreesboro84 Clarksville8

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts